Brief: Virpax Pharmaceuticals Reports 2023 First Quarter Results And Recent Developments
12/05/2023 21:11
Virpax Pharmaceuticals Inc VRPX.O :
* VIRPAX PHARMACEUTICALS REPORTS 2023 FIRST QUARTER RESULTS
AND
RECENT DEVELOPMENTS
* VIRPAX PHARMACEUTICALS INC - AT MARCH 31, 2023, CO HAD
CASH OF
APPROXIMATELY $17.0 MILLION
* VIRPAX PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.13
Source text for Eikon: ID:nBw1fyGMga
Further company coverage: VRPX.O
Recent news on Virpax Pharmaceuticals
See all newsVirpax Pharma plunges as Nasdaq delisting looms
Brief: Virpax Pharmaceuticals Files For Offering On Best Efforts Basis Up To 2.4 Million Shares Of Common Stock
Brief: Virpax receives positive Probudur™ results for dose range study
Brief: Virpax Looking To Use Met To Develop Intranasal Covid Vaccine
Brief: Virpax Confirms Positive Results With Us Army With Probudur™ For Combat Care Study